Related Experiment Video
Updated: Jun 11, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Mirtazapine-Induced Asymptomatic Hepatotoxicity: A Case Report
Rim Sellami1, Ines Feki2, Jawaher Masmoudi3
1Sellami, Department of Psychiatry A, Hedi Chaker University Hospital, University of Sfax, Tunisia.
Low-dose mirtazapine can cause liver injury (DILI) in some patients. Hepatic monitoring is recommended during mirtazapine treatment, even for insomnia, to detect potential liver enzyme elevations.
Area of Science:
- Pharmacology
- Hepatology
- Clinical Medicine
Background:
- Mirtazapine is an antidepressant medication also used for insomnia.
- Drug-induced liver injury (DILI) is a potential adverse effect of many medications.
- Elevated liver enzymes can indicate hepatic dysfunction.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug toxicity: Idiosyncratic Reactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Risk factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Encephalopathy